Orderly Meds
42
Quality Score
Emerging
Orderly Meds
Low confidence
✍️ bumetric analysis
“
Orderly Meds is an iOS app from Orderly Wellness in the Education category, currently rated 3.6★ across 17 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 42: Emerging (early traction worth watching). For a Education app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$126
per month
→
12-mo forecast
$63 – $588
per month
→
24-mo forecast
$63 – $1762
per month
MICRO tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$60K
↳ What it cost to build · not monthly revenue
Likely range $45K – $80K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Slow ROI — current MRR is well below build cost
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Education complexity ×1.20 | +$10K |
Total estimate
$60K
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$126/mo · ML-estimated from 234 triggers
Growth rate
+8.0% MoM · MICRO tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition, low defensibility moat
6 months
$80 – $321
12 months
$63 – $588
24 months
$63 – $1.8K
Compound growth at +8.0% MoM (tier baseline for MICRO). Range widens with horizon — typical noise band ±60% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Insufficient data · 33/100MICRO TIERtoo early to scoreRevenue Strength
2.1
Product Quality
2.9
Market Position
0.3
Growth Velocity
5.0
Defensibility
2.2
Operational Safety
10.0
Founder Strength
2.9
Monetization Maturity
1.0
- 💰 Revenue: Marginal — $0 - $500/mo · MICRO tier · indicative confidence, trajectory unclear.
- ⭐ Quality: 3.6★ across 17 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: dev shipping weekly.
- ⚠️ Risk: Low — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $2K-$4K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 4 of 4 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Ad-supported / freemiumMETRIC | +$600 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (17 ratings)METRIC | −$300 | |
| Growing app (1y old)METRIC | +$200 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v2.4.9
This build includes minor bug fixes.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Orderly Meds
- Developer
- Orderly Wellness
- Bundle ID
- Not found
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $86/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth21 ratings+2000% lifetimeShow 3-year history estimate ▾
Tracked (7 weeks) Pre-tracking estimate (13 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
OrderlyMeds: Telehealth for convenient, online prescription weight loss to support your overall health and well-being. Get access to affordable GLP-1 medications so you can lose weight and keep it off.
With our app you can track your recent orders, view your loyalty discount points, and see how much you’ve already earned towards any future purchases from referring family and friends through our referral program.
Please note: Content in the OrderlyMeds app is for informational purposes only and does not constitute medical advice.… View full description on the official store →
With our app you can track your recent orders, view your loyalty discount points, and see how much you’ve already earned towards any future purchases from referring family and friends through our referral program.
Please note: Content in the OrderlyMeds app is for informational purposes only and does not constitute medical advice.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 21 MB🔞 17+📱 iOS 18.0+🔖 v2.4.9🔄 updated 0d ago🌐 EN📂 Education💰 Paid
📅
What Worked™ · Development Pipeline
5 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-03
⭐
Rating ↑ 2.80 → 3.60 (improved 0.80★)
2026-03
📈
Crossed 10 ratings — social-proof flywheel kicking in
2026-02
⭐
Rating ↑ 1.67 → 2.50 (improved 0.83★)
2026-02
⭐
Rating ↓ 3.00 → 2.00 (dropped 1.00★)
2026-01
🚀
First tracked snapshot — initial data captured
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
About this analysis
Why low confidence: only 17 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
📌 Final verdict — read this before you trust the numbers above
Orderly Meds is a small / niche iOS app in the education space with weak public traction — only 17 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does Orderly Meds make per month?▴
Our model estimates Orderly Meds earns roughly $86/mo, but with only 17 ratings the confidence interval is wide. No founder-verified MRR is available for this app, so this is a model output calibrated against comparable apps in the same category. See methodology for the formula.
What apps are like Orderly Meds?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes Orderly Meds?▴
Orderly Meds is published by Orderly Wellness on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Orderly Meds's BU Score?▴
Orderly Meds has a BU Score of 42/100 (Emerging). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.